2025

Phospholipid-based nanolipid carriers for dual kinase inhibitors in triple-negative breast cancer

Alruwaili, Nabil K.;Almalki, Waleed H;Almujri, Salem Salman;Alhamyani, Abdulrahman;Alzahrani, Abdulaziz;Aodah, Alhussain;Alrobaian, Majed;Singh, Tanuja;Barkat, Md. Abul;Alanezi, Abdulkareem Ali;Singh, Anjali;Haji, Esraa M.;Rahman, Mahfoozur

Description

Current research is focused on developing phospholipid-based nanolipidic carrier (NLC) to deliver lapatinib (LNB) and imatinib (INB) to MDA-MB-231 breast cancer cells and an in vivo mammary tumor model. Breast cancer (BC) was induced in female rats via the chemical carcinogen 7, 12-dimethylbenz(a)anthracene (DMBA). The dual drug-loaded phospholipid-based NLC were made via a hot microemulsion process. The developed NLC were also characterized, and tested in vitro, in vivo, and in a preclinical setting in a DMBA-induced rat model. The dual drug-loaded phospholipid NLC exhibited favorable nanometric size (279.7 nm, PDI 0.323), high entrapment efficiency (94.21%), and robust loading capacity (13.11%). It achieved biphasic drug release (52.67% at 4 h; 92.12% cumulative), potent cytotoxicity with maximal IC₅₀ reduction at 48 h, and maintained stability under accelerated conditions. In vivo, it significantly reduced tumor burden, normalized hematological and biochemical markers, and demonstrated therapeutic efficacy in DMBA-induced breast cancer, highlighting its translational potential. The dual drug-loaded NLC not only achieved high entrapment efficiency but also enhanced cytotoxicity against MDA-MB-231 cells and significantly reduced tumor progression. The developed lipid-based nanocarrier system demonstrates strong potential as a targeted platform for the co-delivery of kinase inhibitors, addressing the therapeutic limitations associated with monotherapy and conventional drug formulations.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.8

FAIR Score

85%

Citations

1

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Taylor & Francis

License

Creative Commons Attribution 4.0 International

Assigned Domain

Subfield

Pharmacology

Field

Pharmacology, Toxicology and Pharmaceutics

Domain

Life Sciences

Confidence Score

52%

Source

Scholar Data Model

Keywords

BiophysicsBiochemistrySpace ScienceMedicineMolecular BiologyPharmacologyBiotechnologyChemical Sciences not elsewhere classifiedBiological Sciences not elsewhere classifiedCancer

Normalization Factors

FT

60.58

CTw

1.00

MTw

1.00